Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nature’s Sunshine Products, Inc. filings document the public-company record for a Nasdaq-listed Utah corporation that manufactures and markets herbal and nutritional supplements and personal care products. Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, material-event disclosures, executive appointments, compensatory arrangements, material agreements and capital-structure updates for NATR common stock.
Proxy materials cover board elections, governance practices, executive compensation, equity awards, pay-versus-performance disclosure and shareholder voting matters. The filing record also addresses risk, regulatory and business disclosures related to the company’s global wellness product operations and distribution markets.
NATURES SUNSHINE PRODUCTS INC EVP & CFO Leslie Shane Jones reported compensation-related share activity in Common Shares on May 5, 2026. He exercised awards to acquire 2,484 shares in one transaction and 4,004 shares in another, and had 1,090 and 1,756 shares withheld to cover taxes at $25.915 per share. The vested shares resulted from achieving adjusted EBITDA milestones of $51.1M and $52M under performance-based restricted stock unit grants. After these transactions, he directly held 103,264 common shares. These were tax and award-related entries, not open-market trades.
NATURES SUNSHINE PRODUCTS INC senior vice president and chief accounting officer Jonathan David Lanoy reported routine equity compensation activity in common shares. Performance-based restricted stock units vested after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. To cover related tax obligations, 912 shares of NATR common stock were withheld at $25.915 per share. Following these vesting and tax-withholding transactions, Lanoy directly holds 40,366 common shares.
Natures Sunshine Products EVP & President, Asia Daniel C. Norman reported compensation-related share activity. On May 5, 2026, performance-based restricted stock units vested after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12‑month periods. These vestings resulted in multiple grants converting into common shares for the executive.
To cover associated tax liabilities upon vesting, a total of 2,104 common shares were withheld at a price of $25.915 per share, recorded as tax-withholding dispositions rather than open-market sales. Following these transactions, Norman directly holds 42,169 common shares of NATR.
Natures Sunshine Products Chief Executive Officer Kenneth G. Romanzi reported equity compensation activity tied to performance-based restricted stock units. After the company achieved an adjusted EBITDA milestone of $52M over a rolling 12-month period, 13,118 common shares vested for him.
To cover related tax obligations upon vesting, 5,753 common shares were withheld at a value of $25.915 per share, rather than sold in the open market. Following these compensation and tax-withholding movements, Romanzi directly holds 110,246 common shares of NATR.
Natures Sunshine Products EVP & President, Europe, Bryant J. Yates reported routine equity compensation activity. On May 5, 2026, he exercised performance-based awards to acquire a total of 6,798 Common Shares and had 1,963 shares withheld to cover tax obligations.
The awards vested after the company achieved adjusted EBITDA milestones of $51.1M and $52M over rolling 12-month periods under performance-based restricted stock unit grants made in 2022, 2023, and 2025. The tax-withholding dispositions were priced at $25.915 per share and were not open-market sales.
Nature’s Sunshine Products reported a strong first quarter of 2026, with net sales rising 9% to $122.9 million and GAAP diluted EPS increasing 16% to $0.29. Adjusted EBITDA grew 33% to $14.6 million as gross margin improved to 73.2% and SG&A leveraged slightly on higher sales. All regions delivered sales growth, and the company ended the quarter with $87.6 million in cash and no debt after repurchasing 20,000 shares for $0.5 million. Management reaffirmed its 2026 outlook for net sales of $500–$515 million and adjusted EBITDA of $50–$54 million. Shareholders approved all proxy items, including a new 2026 Stock Incentive Plan reserving up to 1,500,000 shares for equity awards.
NATURES SUNSHINE PRODUCTS INC EVP and General Counsel Nathan G. Brower reported a routine tax-related share disposition. On April 20, 2026, 1,289 common shares of NATR were withheld at $27.07 per share to cover taxes when restricted stock units granted on April 20, 2023 vested. After this withholding, he directly holds 42,345 common shares.
NATURES SUNSHINE PRODUCTS INC EVP & CFO Leslie Shane Jones reported a tax-related share disposition. On April 20, 2026, 3,512 Common Shares of NATR were withheld at $27.07 per share to cover taxes upon vesting of restricted stock units granted on April 20, 2023. After this withholding, Jones directly holds 101,016 Common Shares. This was a compensation-driven tax-withholding transaction rather than an open-market sale.
NATURES SUNSHINE PRODUCTS INC SVP and Chief Accounting Officer Jonathan David Lanoy had 951 Common Shares withheld to cover taxes on vested equity. The shares were withheld on April 20, 2026 at a price of $27.07 per share, tied to restricted stock units granted on April 20, 2023. After this tax-withholding disposition, he directly holds 40,039 Common Shares, indicating this was a routine compensation-related event rather than an open-market trade.